[1]李贺,郑荣寿,张思维,等.2014年中国女性乳腺癌发病与死亡分析[J].中华肿瘤杂志,2018,40(3):166-171.
LI H,ZHENG RS,ZHANG SW,et al.Analysis of the incidence and mortality of breast cancer in Chinese women in 2014 [J].Chinese Journal of Oncology,2018,40(3):166-171.
[2]中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2019年版)[J].中国癌症杂志,2019,29(8):609-680.
Breast Cancer Professional Committee of China Anti-Cancer Association.Guidelines for the diagnosis and treatment of breast cancer by the Chinese Anti-Cancer Association(2019 edition)[J].Chinese Journal of Cancer,2019,29(8):609-680.
[3]孙笑芬,邢伟,俞胜男,等.对比增强能谱乳腺X线摄影量化评分对定性乳腺病灶的价值[J].临床放射学杂志,2020,39(9):1738-1742.
SUN XF,XING W,YU SN,et al.The value of contrast-enhanced spectral mammography quantification score in the differential diagnosis of breast lesions [J].Journal of Clinical Radiology,2017,51(4):273-278.
[4]DROMAIN C,THIBAULT F,MULLER S,et al.Dual-energy contrast-enhanced digital mammography:initial clinical results[J].Eur Radiol,2011,21:565-574.
[5]LEWIN JM,ISAACS PK,VANCE V,et al.Dual-energy contrast-enhanced digital subtraction mammography:feasibility[J].Radiology,2003,229:261-268.
[6]史军华,张体江,张道恩,等.乳腺对比增强能谱X线摄影的分析[J].广东医学,2019,40(1):140-143.
SHI JH,ZHANG TJ,ZHANG DE,et al.Analysis of contrast-enhanced mammography [J].Guangdong Medical Journal,2019,40(1):140-143.
[7] DANIAUX M,ZORDO TD,SANTNER W,et al.Dual-energy contrast-enhanced spectral mammography(CESM)[J].Arch Gynecol Obstet,2015,292(4):1-8.
[8]LOBBES MB,SMIDT ML,HOUWERS J,et al.Contrast enhanced mammography:Techniques,current results,and potential indications [J].Clinical Radiology,2013,68:935-944.
[9]曲玉虹,陈倩倩,曹崑.对比增强能谱乳腺X线摄影的临床应用及进展[J].中国医学影像技术,2019,35(4):36-39.
QU YH,CHEN QQ,CAO K.Clinical application and progress of contrast enhanced energy spectrum mammography [J].China Medical Imaging Technology,2019,35(4):36-39.
[10]JAMES JR,PAVLICEK W,HANSON JA,et al.Breastradiation dose with CESM compared with 2D FFDM and 3D tomosynthesis mammography[J].Medical Physics and Informatics,2016,208:362-372.
[11]MENEZES GJG,WINTER-WARNARS GA,KOEKENBIER EL,et al.Simplifying breast imaging reporting and data system classification of mammograms with pure suspicious calcifications[J].J Med Screen,2018,25(2):82-87.
[12]LALJI UC,JEUKENS CP,HOUBEN H,et al.Evaluation of low-energy contrast-enhanced spectral mammography images by comparing them to full-field digital mammography using EUREF image quality criteria[J].Eur Radiol,2015,25(10):1-8.
[13]MOHAMED SAS,MOFTAH SG,CHALABIA NAEM,et al.Added value of contrast-enhanced spectralmammography in symptomatic patientswith dense breasts [J].Egyptian Journal of Radiologyand Nuclear Medicine,2021,52(8):1-10.
[14]CHEUNG YC,TSAI HP,LO YF,et al.Clinical utility of dua-lenergycontras-tenhanced spectral mammography for breast microcalcificationswithout associated mass:a preliminary analysis [J].Eur Radiol,2016,26(4):1082-1089.
[15]TRAVIESO-AJA MM,SALUZZI MM,SANTANA PN,et al.Diagnostic performance of contrast enhanced dual energy spectral mammography(CESM):a retrospective study involving 644 breast lesions [J].La Radiologia Medica,2019,124(10):1-12.
[16]KAMALA RM,HELALB MH,WESSAM R,et al.Contrast-enhanced spectral mammography:Impact of the qualitativemorphology descriptors on the diagnosis of breast lesions[J].European Journal of Radiology,2016,84(6):1-7.
[17]FALLENBERG EM,SCHMITZBERGER LF,AMER H,et al.Contrast-enhanced spectral mammography vs mammographyand MRI-clinical performance in a multi-reader evaluation [J].Eur Radiol,2017,27(7):1-13.
[18]MORI M,AKASHI-TANAKA S,SUZUKI S,et al.Diagnostic accuracy of contrast-enhanced spectral mammographyin comparison to conventional full-field digital mammographyin a population of women with dense breasts[J].Breast Cancer,2017,24(1):1-7.
[19]MOKHTAR O,MAHMOUD S.Can contrast enhanced mammography solvethe problem of dense breast lesions[J].The Egyptian Journal of Radiology and Nuclear Medicine,2014,45:1043-1052.
[20]LUCZYNSKA E,HEINZE S,ADAMCZYK A,et al.Comparison of the mammography,contrast-enhanced spectral mammography and ultrasonography in a group of 116 patients [J].Anticancer Research,2016,36(8):4359-4366.
[21]KATRIN S,RUBBERT C,MMTHYS B,et al.Blum.Use of contrast-enhanced spectralmammography for intramammary cancer staging:preliminary results[J].Academic Radiology,2014,21(11):1363-1369.
[22]邹明,王永杰,金彪,等.对比增强能谱乳腺X线摄影与CE-MRI对乳腺疾病诊断效能的比较[J].中国医学计算机成像杂志,2018,24(3):211-214.
ZOU M,WANG YJ,JIN B,et al.Comparison of contrast-enhanced energy spectrum mammography and CE-MRI in the diagnosis of breast diseases [J].Chinese Journal of Medical Computer Imaging,2018,24(3):211-214.
[23]RABAB Y,ENAS-ABD.BIRADS 4 breast lesions:comparison of contrast-enhanced spectral mammography and contrast-enhanced MRI [J].Egyptian Journal of Radiologyand Nuclear Medicine,2019,50(34):1-10.
[24]RUDNICKI W,PIEGZA T,GORSKI M,et al.The effectiveness of contrast-enhanced spectral mammography and magnetic resonance imaging in dense breasts[J].Polish Journal of Radiology,2021,86:159-164.
[25]LOBBES MB,LALJI UC,NELEMANS PJ,et al.The quality of tumor size assessment by contrast enhanced spectral mammography and the benefit of additional breast MRI[J].Journal of Cancer,2015,6:144-150.
[26]HOUBEN IP,VANWETSWINKEL S,KALIA V,et al.Contrast-enhanced spectral mammography in the evaluation of breast suspicious calcifications:diagnostic accuracy and impact on surgical management [J].Acta Radiologica,2019,60(9):1110-1117.
[27]陈坜桃,黄林,张雪琴,等.对比增强能谱乳腺X线摄影针对乳腺可疑性钙化的诊断价值[J].四川医学,2020,41(5):514-518.
CHEN LT,HUANG L,ZHANG XQ,et al.Diagnostic value of CESM for suspicious calcification of breast[J].Sichuan Medical Journal,2020,41(5):514-518.
[28] XING D,MAO N,LYU YB,et al.Quantitative analysis of contrast enhanced spectral mammography grey value for early prediction of pathological response of breast cancer to neoadjuvant chemotherapy[J].Scientific Reports,2021,11:5892.
[29]COSTANTINI M,MONTELLA RA,FADDA MP,et al.Axillarynodal metastases from carcinoma of unknownprimary(cupax):role of contrast-enhanced spectralmammography(CESM)in detecting occult breast cancer[J].Journal of Personalized Medicine,2021,11:465:1-10.
[30]HOUBEN IP,VOORDE PV,JEUKENSA CR,et al.Contrast-enhanced spectral mammography as work-up tool in patients recalled from breast cancer screening has low risks and might hold clinical benefits[J].European Journal of Radiology,2017,94:31-37.
[31] KNOGLER T,HOMOLKA P,HOERNIG M,et al.Application of BI-RADS descriptors in contrast-enhanced dual-energy mammography:comparison withMRI [J].Breast Care,2017,12(4):212-216.